Tesamorelin is not approved for general weight loss and should not be used as a weight-loss medication in individuals without HIV-associated lipodystrophy. Its mechanism of action is specifically targeted toward reducing visceral fat in the context of lipodystrophy, and its effects on general obesity are not well-documented.